Search hospitals > Missouri > Kansas City
University of Kansas Cancer Center
Claim this profileKansas City, Missouri 64131
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Leukemia
Conducts research for Lung Cancer
435 reported clinical trials
47 medical researchers
Summary
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Leukemia, Lung Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 581 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Gary C. Doolittle, Chao H. Huang, and Andrea D. Jewell.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Jun ZhangHouston Methodist Hospital4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
25 reported clinical trials
40 drugs studied
Gary C. DoolittleHaysMed University of Kansas Health System3 years of reported clinical research
Studies Cancer
Studies Melanoma
18 reported clinical trials
29 drugs studied
Chao H. HuangUniversity of Kansas Health System Saint Francis Campus5 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
19 reported clinical trials
31 drugs studied
Andrea D. JewellUniversity of Kansas Cancer Center4 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
16 reported clinical trials
38 drugs studied
Clinical Trials running at University of Kansas Cancer Center
Breast Cancer
Prostate Cancer
Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Bladder Cancer
Lung Cancer
Non-Hodgkin's Lymphoma
Lymphoma
Tumors
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Kansas Cancer Center?
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Leukemia, Lung Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 581 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Gary C. Doolittle, Chao H. Huang, and Andrea D. Jewell.
Where is University of Kansas Cancer Center located?
The University of Kansas Cancer Center offers comprehensive medical oncology services at its facility located at 12200 West 110th Street, Overland Park, KS 66210. For inquiries or to schedule an appointment, please call 913-588-1227.
Who should I call to ask about financial aid or insurance network?
The University of Kansas Cancer Center offers comprehensive support services for cancer patients, including emotional, nutritional, financial, and genetic counseling, personal appearance services, and rehabilitation. Patients eligible for financial assistance, with a gross family income between 0% to 300% of the federal poverty guidelines, can apply through the University of Kansas Health System. For more details or to make an appointment, contact 913-588-1227 or toll-free at 844-323-1227.
What insurance does University of Kansas Cancer Center accept?
The University of Kansas Cancer Center accepts a wide range of insurance plans, including those through the University of Kansas Medical Center for its employees, covering medical, dental, vision, disability, long-term care, life insurance, and wellness programs. Additionally, it accepts various plans on the open marketplace, including Aetna CareLink, BCBS Kansas, Sunflower or Home State/Ambetter, Oscar, and Blue Cross Blue Shield of Kansas City/Blue Select. It's important to verify with your physician that they participate with your insurance plan or network before seeking services.
What awards or recognition has University of Kansas Cancer Center received?
The University of Kansas Cancer Center, located in Kansas City, Missouri, is recognized as a Comprehensive cancer center by the National Cancer Institute (NCI), a prestigious status shared with only 53 centers nationwide. This distinction is accompanied by a five-year, $13.8 million grant aimed at bolstering the center's research efforts. In partnership with the Stowers Institute for Medical Research and Children's Mercy Kansas City, the center enhances its research capabilities and extends its services to high-risk and underserved communities.